Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Julian Harrison's Stock Ratings
BTIG Analyst
Julian Harrison is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/17/2025
Overall Average Return
-12.2%
Smart Score
Overall Average Return Percentile
17th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/19/2024 | AVTX | Buy Now | Avalo Therapeutics | $4.60 | 769.57% | Julian Harrison37% | → $40 | Initiates | → Buy | Get Alert |
| 12/19/2024 | RNAC | Buy Now | Cartesian Therapeutics | $10.25 | 309.76% | Julian Harrison37% | → $42 | Initiates | → Buy | Get Alert |
| 12/12/2024 | KROS | Buy Now | Keros Therapeutics | $13.54 | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/02/2024 | ANAB | Buy Now | AnaptysBio | $23.59 | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/29/2024 | OTLK | Buy Now | Outlook Therapeutics | $1.72 | 423.26% | Julian Harrison37% | $50 → $9 | Maintains | Buy | Get Alert |
| 11/19/2024 | ACRS | Buy Now | Aclaris Therapeutics | $1.49 | 438.72% | Julian Harrison37% | → $8 | Upgrade | Neutral → Buy | Get Alert |
| 11/18/2024 | VYNE | Buy Now | VYNE Therapeutics | $0.92 | 769.57% | Julian Harrison37% | → $8 | Initiates | → Buy | Get Alert |
| 10/18/2024 | OTLK | Buy Now | Outlook Therapeutics | $1.72 | 2806.98% | Julian Harrison37% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.66 | 289.53% | Julian Harrison37% | $56 → $61 | Maintains | Buy | Get Alert |
| 09/10/2024 | RZLT | Buy Now | Rezolute | $4.32 | 247.22% | Julian Harrison37% | $13 → $15 | Maintains | Buy | Get Alert |
| 09/10/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.66 | 257.6% | Julian Harrison37% | $46 → $56 | Maintains | Buy | Get Alert |
| 08/20/2024 | LQDA | Buy Now | Liquidia | $13.95 | 79.27% | Julian Harrison37% | $29 → $25 | Maintains | Buy | Get Alert |
| 08/19/2024 | LQDA | Buy Now | Liquidia | $13.95 | 79.27% | Julian Harrison37% | $29 → $25 | Maintains | Buy | Get Alert |
| 07/24/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.65 | -6.68% | Julian Harrison37% | $41 → $51 | Maintains | Buy | Get Alert |
| 07/17/2024 | RZLT | Buy Now | Rezolute | $4.32 | 200.93% | Julian Harrison37% | → $13 | Initiates | → Buy | Get Alert |
| 06/17/2024 | AVTE | Buy Now | Aerovate Therapeutics | — | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/20/2024 | ABVX | Buy Now | Abivax | $6.66 | 545.65% | Julian Harrison37% | → $43 | Initiates | → Buy | Get Alert |
| 05/10/2024 | SYRE | Buy Now | Spyre Therapeutics | $17.15 | 133.24% | Julian Harrison37% | $32 → $40 | Maintains | Buy | Get Alert |
| 04/12/2024 | TBPH | Buy Now | Theravance Biopharma | $10.80 | 94.35% | Julian Harrison37% | → $21 | Initiates | → Buy | Get Alert |
| 03/27/2024 | OTLK | Buy Now | Outlook Therapeutics | $1.72 | 2806.98% | Julian Harrison37% | → $50 | Upgrade | Neutral → Buy | Get Alert |
| 02/26/2024 | ANAB | Buy Now | AnaptysBio | $23.59 | 133.15% | Julian Harrison37% | → $55 | Initiates | → Buy | Get Alert |
| 02/13/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/11/2024 | ACRS | Buy Now | Aclaris Therapeutics | $1.49 | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/20/2023 | SYRE | Buy Now | Spyre Therapeutics | $17.15 | 86.59% | Julian Harrison37% | → $32 | Initiates | → Buy | Get Alert |
| 12/20/2023 | APGE | Buy Now | Apogee Therapeutics | $41.99 | 2.41% | Julian Harrison37% | → $43 | Initiates | → Buy | Get Alert |
| 11/29/2023 | AKBA | Buy Now | Akebia Therapeutics | $3.56 | 12.36% | Julian Harrison37% | → $4 | Assumes | → Buy | Get Alert |
| 10/11/2023 | MTNB | Buy Now | Matinas BioPharma Hldgs | $0.91 | 228.05% | Julian Harrison37% | $3 → $3 | Reinstates | Buy → Buy | Get Alert |
| 09/25/2023 | MORF | Buy Now | Morphic Holding | — | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/08/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | $22 → $24 | Maintains | Buy | Get Alert |
| 08/30/2023 | OTLK | Buy Now | Outlook Therapeutics | $1.72 | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/11/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | $18 → $22 | Maintains | Buy | Get Alert |
| 07/05/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | $15 → $18 | Maintains | Buy | Get Alert |
| 07/03/2023 | PTGX | Buy Now | Protagonist Therapeutics | $54.65 | -24.98% | Julian Harrison37% | → $41 | Reiterates | → Buy | Get Alert |
| 06/14/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.66 | 193.74% | Julian Harrison37% | → $46 | Initiates | → Buy | Get Alert |
| 05/15/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | $15 → $15 | Maintains | Buy | Get Alert |
| 05/01/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | $15 → $15 | Maintains | Buy | Get Alert |
| 03/19/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | $15 → $15 | Maintains | Buy | Get Alert |
| 03/09/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Julian Harrison37% | → $15 | Initiates | → Buy | Get Alert |
| 03/09/2023 | MLTX | Buy Now | MoonLake | $42.39 | -15.07% | Julian Harrison37% | → $36 | Initiates | → Buy | Get Alert |
| 03/07/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.49 | 1852.86% | Julian Harrison37% | $32 → $29 | Maintains | Buy | Get Alert |
| 12/13/2022 | KROS | Buy Now | Keros Therapeutics | $13.54 | 675.47% | Julian Harrison37% | $95 → $105 | Maintains | Buy | Get Alert |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Julian Harrison37% | $74 → $181 | Maintains | Buy | Get Alert |
| 12/06/2022 | AVTE | Buy Now | Aerovate Therapeutics | — | — | Julian Harrison37% | → $27 | Upgrade | Neutral → Buy | Get Alert |
| 10/31/2022 | OTLK | Buy Now | Outlook Therapeutics | $1.72 | 306.98% | Julian Harrison37% | → $7 | Initiates | → Buy | Get Alert |
| 10/06/2022 | ACRS | Buy Now | Aclaris Therapeutics | $1.49 | 2054.88% | Julian Harrison37% | → $32 | Initiates | → Buy | Get Alert |
| 10/03/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Julian Harrison37% | $62 → $74 | Maintains | Buy | Get Alert |
| 08/16/2022 | AVTE | Buy Now | Aerovate Therapeutics | — | — | Julian Harrison37% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/26/2022 | KROS | Buy Now | Keros Therapeutics | $13.54 | 490.84% | Julian Harrison37% | → $80 | Initiates | → Buy | Get Alert |
| 07/20/2022 | LQDA | Buy Now | Liquidia | $13.95 | 21.9% | Julian Harrison37% | $14 → $17 | Maintains | Buy | Get Alert |
| 05/03/2022 | PROG | Buy Now | Biora Therapeutics | — | — | Julian Harrison37% | → $4 | Assumes | → Buy | Get Alert |
| 02/11/2022 | AVTE | Buy Now | Aerovate Therapeutics | — | — | Julian Harrison37% | → $24 | Initiates | → Buy | Get Alert |
| 02/11/2022 | UTHR | Buy Now | United Therapeutics | $286.25 | — | Julian Harrison37% | — | Initiates | → Neutral | Get Alert |
| 02/11/2022 | MORF | Buy Now | Morphic Holding | — | — | Julian Harrison37% | → $64 | Initiates | → Buy | Get Alert |
| 02/11/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Julian Harrison37% | → $62 | Initiates | → Buy | Get Alert |
| 01/06/2015 | UTHR | Buy Now | United Therapeutics | $286.25 | — | Julian Harrison37% | — | Initiates | → Neutral | Get Alert |
